您现在的位置: 首页> 研究主题> Marfan综合征

Marfan综合征

Marfan综合征的相关文献在1992年到2020年内共计99篇,主要集中在内科学、眼科学、外科学 等领域,其中期刊论文98篇、会议论文1篇、专利文献98889篇;相关期刊71种,包括法医学杂志、齐鲁护理杂志、中华胸心血管外科杂志等; 相关会议1种,包括2014成人脊柱畸形研讨会等;Marfan综合征的相关文献由257位作者贡献,包括伍严安、黄肖利、付文华等。

Marfan综合征—发文量

期刊论文>

论文:98 占比:0.10%

会议论文>

论文:1 占比:0.00%

专利文献>

论文:98889 占比:99.90%

总计:98988篇

Marfan综合征—发文趋势图

Marfan综合征

-研究学者

  • 伍严安
  • 黄肖利
  • 付文华
  • 孙立忠
  • 徐国兴
  • 徐金霞
  • 戴青梅
  • 李淑花
  • 段若芷
  • 王景昭

Marfan综合征

-相关会议

  • 期刊论文
  • 会议论文
  • 专利文献

搜索

排序:

年份

    • 何天文; 卢建; 陈创奇; 刘顿; 丁红珂; 董云巧; 杜丽; 尹爱华
    • 摘要: 目的 探讨二代测序在Marfan综合征家系的植入前遗传学诊断应用价值和优势.方法 针对2016年10月在广东省妇幼保健院医学遗传中心就诊的1例Marfan综合征家系行外显子捕获测序筛查微纤维蛋白(FBN1)基因突变位点,筛查结果通过Sanger测序进行验证,明确基因突变位点.选择FBN1基因编码区及外显子-内含子交界为目标区域,在该基因上下游2 M区域内选择100个高密度紧密连锁的单核苷酸多态位点(SNP)作为遗传连锁标记,构建夫妇单倍型.采用二代测序对胚胎的突变位点直接测序和单体型连锁分析进行植入前遗传学诊断.结果 男方存在FBN1基因c.247+1G>A的致病性突变,经直接测序和单体型连锁分析,患者夫妇的5个囊胚中3个正常,2个致病.选择发育良好且遗传学检测正常的胚胎植入母体子宫,足月分娩一健康婴儿.结论 采用二代测序对Marfan综合征家系进行植入前遗传学诊断可以阻断此单基因病在该家系中的再发风险,还可以避免选择非整倍体胚胎而导致的流产问题,是Marfan综合征出生缺陷的有效预防手段.
    • 周宜静; 杨静; 曹乾忠; 靳光明; 郑丹莹
    • 摘要: 目的 分析5个伴心血管异常的先天性晶状体脱位(CEL)家系基因型与临床表型之间的关联.方法 纳入2017年8月至2018年3月中山大学中山眼科中心收治的5个CEL家系共15例家系成员,进行详细相关临床检查和记录,包括裂隙灯显微镜检查扩瞳前后晶状体情况,心脏超声检查评价心血管系统情况,以及X射线成像评价研究对象骨骼系统系统受累程度.采集15例参与者外周静脉血,提取基因组DNA.同期纳入100名无血缘关系的汉族人群作为对照组.利用靶向外显子捕获测序技术筛查FBN1基因突变,回顾各位点既往文献,并分析可能的基因型-表型关联. 结果 5例先证者均为先天性晶状体脱位患者合并心血管异常,均携带FBN1基因突变,其中4例携带错义突变(c.2741G>T、c.2585G>T、c.1633C>T、c.4260C>G),1例为新发剪切位点突变(c.2114-1G>C).5个突变均预测为导致蛋白质结构的改变. 结论 FBN1基因具高度临床异质性,早期发现眼部表型并结合基因筛查对心血管异常风险的诊断具重要意义.%Objective To analyze the genotype-phenotype correlation in 5 families with congenital ectopia lentis (CEL) accompanied with cardiovascular abnormal manifestation.Methods Detailed clinical data of 15 family members in 5 families were collected from August 2017 to March 2018 in Zhongshan Ophthalmic Center,including examination of the condition of lens before and after mydriasis by slit-lamp,evaluation of the cardiovascular system using transthoracic echocardiography,and evaluation of the degree of involvement of the subjects' skeletal system using X-ray images.Genomic DNAs were extracted from whole blood sample of the 5 probands and 10 relatives,and screened for FBN1 mutation by targeted exome sequencing.The possible genotype-phenotype correlation was analyzed by reviewing previous literatures into these mutation sites.The study followed the principles of the Helsinki Declaration and written informed consent was obtained from each subject prior to any examination.Results All of the five probands were diagnosed as CEL accompanied with cardiovascular abnormal manifestation.FBN1 gene mutations were identified in all of the five probands,including four missense mutations (c.2741G>T,c.2585G>T,c.1633C>T,c.4260C>G) and one splicing mutation (c.2114-1G>C).It was predicted that all of the 5 mutations would alter the protein structure.Conclusions FBN1 gene has a high degree of clinical heterogeneity,and the early detection of ocular phenotypes combined with genetic screening is of great significance in the diagnosis of cardiovascular abnormalities.
    • 沈茜
    • 摘要: 总结了1例Marfan综合征合并右眼晶状体脱位患儿的围手术期护理,包括:术前做好全面检查和评估,术前的眼压控制,疼痛管理,心理护理等,以提高患儿及家长的手术配合度,术后做好患儿的全麻护理,伤口护理,并发症观察及出院指导.经过精心治疗和护理,患儿安全度过围术期,顺利出院.
    • 陈彧; 马维国; 李建荣; 郑军; 朱俊明; 刘永民; 孙立忠
    • 摘要: 目的 探讨应用主动脉全弓替换结加支架象鼻手术(孙氏手术)治疗Bentall术后未手术部位新发A型主动脉夹层累及主动脉弓病变的中远期预后.方法 回顾分析2009年2月至2016年2月141例Stanford A型主动脉夹层累及弓部病变的Mar fan综合征(MFS)患者资料,11例(7.8%)初次因主动脉根部瘤行Bental1手术,其中男10例,年龄(43.2±8.6)岁(26~ 50岁),急诊手术8例,高血压病史4例,家族发病史7例,均行孙氏手术治疗.Bentall手术至孙氏手术时间间隔(11.3±5.8)年.依据术前降主动脉近端直径是否大于> 40 mm分两组.收集所有患者围手术期临床资料和主动脉CTA影像学资料,分析孙氏手术后远端主动脉假腔血栓化程度、主动脉直径变化,远端主动脉扩张和再次手术等早期和中远期预后.结果 11例Bentall术后合并Stanford A型主动脉夹层MFS患者均成功行孙氏手术治疗,无脊髓损伤.术前降主动脉近端直径> 40 mm组患者住院死亡3例,其中1例手术时间长,肺实变合并多脏器功能衰竭;1例围手术期脑梗塞并脑出血;1例远端主动脉破裂.孙氏手术后随访(5.3±2.0)年(2.1~8.1年),随访率100%.远端主动脉假腔血栓化率在支架象鼻近端周围达100%,非支架降主动脉段达75.0%;支架近端无内漏,无远端主动脉破裂.3例远端主动脉缓慢扩张,最大直径达50 mm,拟择期行胸腹主动脉替换手术(TAAAR)术.晚期非心脏原因死亡2例,无再次手术.术前降主动脉近端直径> 40 mm组与≤40 mm组相比,FET支架段降主动脉重塑不明显,差异有统计学意义(P=0.01),在非支架降主动脉段,膈肌和肾动脉水平两组直径差异无统计学意义.Kaplan-Meier生存分析显示,孙氏手术后1个月、1年和6年生存率分别为81.8%,72.7%和63.6%.结论 孙氏手术治疗Bentall术后远端未手术部分新发Stanford A型主动脉夹层累及弓部病变的MFS患者早期死亡比例较高,中长期预后好.术前降主动脉近端直径大于40 mm是早期死亡、远端主动脉扩张和再次手术等主动脉不利事件的重要危险因素.%Objective Stanford type A aortic dissection(TAAD) involving aortic arch in following prior Bentall procedure in patients with Madfan syndrome(MFS) is uncommon.The purpose of the study was to assess the early and long-term outcomes of this kind of patients underwent total arch replacement and frozen elephant trunk (TAR + FET).Methods Between February 2009 and February 2016,141 patients with Marfan syndrome(confirmed by revised Ghent Criteria) underwent TAR + FET for TAAD,of those 11 (7.8 %) patients (8 acute) following a prior Bentall procedure and without dissection in distal aorta.Mean age at FET was(43.2 ± 8.6) years and 10 were males.Hypertension was seen in 4 (36.4%) and family history was seen in 7 (63.6%).The interval from Bentall procedure to FET averaged (11.3 ± 5.8) years.Two groups were segregated by the maximal diameter of descending aorta more than 40 mm or not.The early and long-term outcomes were analyzed and risk factors identified for late adverse events.Results Operative mortality was 27.3 % (3/11).No spinal cord injury occurred.The cause of death was long time of surgery,multiorgan failure,stroke and cerebral hemorrhage and rupture of distal aorta.Follow-up was complete in 100%,averaging(5.3-± 2.0)years(range 2.1-8.1 years).Obliteration of the false lumen was seen in 100% across the proximal FET and 75.0% in the unstented descending aorta.Distal aortic dilation occurred in 3 patients which were waiting open thoracoabdominal aortic repair(TAAAR) but no reoperation yet.Of those 8 patients,2 died of non-cardiac reason.The DMax of FET segment has significant grow in DA more than 40ram group than less than 40mm group (P =0.01).Another segment of distal aorta has no significant different.Survival were 81.8%,72.7% and 63.6% at 1 month,1 year and 6 years after surgery.Conclusion Using Sun's procedure for Marfan patients for type A aortic dissection involving aortic arch following previous Bentall procedure was safe and technically feasible with good long-term outcomes,but higher early death.The DMax of descending aorta more than 40mm was at higher risk for early death,late distal aortic dilation,and reoperation.
    • 郭义山; 丛超; 杨宁; 王东
    • 摘要: Aortic dissection is a critical cardiovascular disease,which is seriously harmful to human health,featured with a rapid onset and atypical clinical symptoms,which may easily result in misdiagnosis and mistreatment.The pathogenic factors of this disease is numerous,and the pathogenesis is not clear.At present,the research of pathogenesis is mainly focused on genetic factors, inflammatory mechanisms,oxidative stress and trauma.The characteristics of diagnosis and treatment of aortic dissection in China are as follows:a variety of clinical manifestations and complications,age of onset tends to be young, high mortality.The main cause of death of the disease is the rupture of aortic dissection to the chest,abdominal cavity or pericardial cavity,progressive mediastinal and retroperitoneal hemorrhage,and acute heart failure or renal failure.Here is to make a review of the current situation,problems and latest progress in the field of aortic dissection,so as to improve the cognition of the clinicians on this disease,and provide references for the diagnosis and treatment.%主动脉夹层是一种严重危害人类健康的心血管急危重症,其发病迅速,临床症状不典型,极易误诊、误治.其发病因素众多,发病机制尚不明确,目前发病机制的研究主要集中在遗传因素、炎症机制、氧化应激以及外伤等方面.我国主动脉夹层的诊疗特点是临床表现多种多样,发病年龄趋于年轻,病死率较高,临床并发症多.该病的主要致死原因为主动脉夹层动脉瘤破裂至胸、腹腔或者心包腔,进行性纵隔、腹膜后出血,以及急性心力衰竭或者肾衰竭.该文就主动脉夹层领域内的现状、问题及最新进展进行综述,提高临床医师对该病的认识和重视,为主动脉夹层的诊治提供依据.
    • 赵燕; 何俊文; 吴建华
    • 摘要: 目的:评价23G微创玻璃体切除术治疗Marfan综合征合并视网膜脱离的临床疗效.方法:回顾性分析6例患者9眼运用23G微创玻璃体切除术后的解剖及视功能恢复情况.结果:术后随访3~ 12个月,平均6个月,玻璃体切除术后8眼视网膜脱离一次复位成功,复位率为88.9%1眼视网膜未复位者,再次手术后视网膜复位.与术前视力相比,7眼视力有不同程度的提高(77.78%),2眼视力无明显改变(22.22%).结论:23G玻璃体切除术是一种治疗Marfan综合征合并视网膜脱离的有效方法.
    • 杨先洲; 张红卫
    • 摘要: 1、临床资料:患者,青年,男性,26岁,因“咳嗽、心悸10天、胸痛、胸闷1小时”入院,患者既往有“Marfan综合征”病史10+年,曾于遵义医学院附属医院明确诊断,未予以任何治疗,家族中否认Marfan病史。10+天患者因受凉后出现咳嗽、咳痰,为白色泡沫痰,并感心悸、乏力,无畏寒,发热,否认盗汗、纳差,无咳血、胸痛、晕厥及夜间阵发性呼吸困难,否认端坐呼吸,双下肢水肿及头昏等不适;
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号